Previous genome-wide association studies identified two susceptibility loci for osteosarcoma, one of which that achieved genome-wide significance was a single nucleotide intronic variant, rs1906953, at 6p21.3, in the glutamate receptor metabotropic 4 (GRM4) gene (19). Here, GRM4 is linked to osteosarcoma.